Adherence to treatment in patients with borderline personality disorder (BPD) with gynecological cancer

Introduction The presence of borderline personality disorder (BPD) in cancer patients can be a risk factor for adherence to oncological treatment. Objectives To analyze problems related to adherence to treatment of patients with borderline personality disorder (BPD) in comorbidity with gynecological cancer. Methods Clinical histories and subsequent interviews of patients (“A” and “B”), both 25 years of age. “A” with a diagnosis of Cervical Cancer in 2022, without adherence to treatment, irritable, unmotivated, with emotional instability in her relationships, chronic emptiness, impulsivity, risky sexual behaviors, self-harm, and suicidal thoughts. B, diagnosed with endometrial cancer in January 2023, presents treatment adherence with extreme fear of abandonment, irritability, anhedonia, anxiety, low self-esteem, impulsivity, and suicidal ideas. Both receive psychotherapy at the Psychooncology and Palliative Care clinic. Scales from the General Health Questionnaire (GHQ-28) and McLean Screening Instrument for Borderline Personality Disorder were applied. Results Anxiety, lack of control, and rebellion manifested A’s lack of adherence. B’s “adherence” is redefined as separation anxiety, currently deposited in her partner and the oncology team. They evoked physical and sexual violence experienced since childhood and drug abuse, which influenced her anger and attitude towards cancer treatment for being “captives” of the disease. Thus, she denied A her dependency needs and B her fear of her partner’s abandonment and her suicidal thoughts. Conclusions Internal conflicts are expressed through self-destructive behavior: addressing her fears allowed her to continue treatment. Psychotherapy limited his judgment, cognitive, and reasoning lapses. They mentalized stories of abuse, early violence, and behaviors that limited their quality of life before and after cancer, improving their treatment adherence. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.1904
Primary Topic
Personality Disorders and Psychopathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adherence to treatment in patients with borderline personality disorder (BPD) with gynecological cancer

C. Martinez, Adelina Alcorta-Garza, Annette Lynn Cantu, Miguel Garza
European Psychiatry
Personality Disorders and Psychopathology
article

Adherence to treatment in patients with borderline personality disorder (BPD) with gynecological cancer

C. Martinez, Adelina Alcorta-Garza, Annette Lynn Cantu, Miguel Garza
article en

Abstract

Introduction The presence of borderline personality disorder (BPD) in cancer patients can be a risk factor for adherence to oncological treatment. Objectives To analyze problems related to adherence to treatment of patients with borderline personality disorder (BPD) in comorbidity with gynecological cancer. Methods Clinical histories and subsequent interviews of patients (“A” and “B”), both 25 years of age. “A” with a diagnosis of Cervical Cancer in 2022, without adherence to treatment, irritable, unmotivated, with emotional instability in her relationships, chronic emptiness, impulsivity, risky sexual behaviors, self-harm, and suicidal thoughts. B, diagnosed with endometrial cancer in January 2023, presents treatment adherence with extreme fear of abandonment, irritability, anhedonia, anxiety, low self-esteem, impulsivity, and suicidal ideas. Both receive psychotherapy at the Psychooncology and Palliative Care clinic. Scales from the General Health Questionnaire (GHQ-28) and McLean Screening Instrument for Borderline Personality Disorder were applied. Results Anxiety, lack of control, and rebellion manifested A’s lack of adherence. B’s “adherence” is redefined as separation anxiety, currently deposited in her partner and the oncology team. They evoked physical and sexual violence experienced since childhood and drug abuse, which influenced her anger and attitude towards cancer treatment for being “captives” of the disease. Thus, she denied A her dependency needs and B her fear of her partner’s abandonment and her suicidal thoughts. Conclusions Internal conflicts are expressed through self-destructive behavior: addressing her fears allowed her to continue treatment. Psychotherapy limited his judgment, cognitive, and reasoning lapses. They mentalized stories of abuse, early violence, and behaviors that limited their quality of life before and after cancer, improving their treatment adherence. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
Hospital Universitario Dr José Eleuterio Gonzalez (MX)
Openalex Percentile: Top 66%
Personality Disorders and Psychopathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.